摘要
目的探究经皮穿刺椎体成形术治疗骨质疏松性椎体骨折不愈合的可行性。方法选择渭南市第三人民医院2012年5月至2015年5月84例骨质疏松性椎体骨折不愈合患者,其中男性45例,女性39例;年龄61-79岁,平均年龄66.43岁。将其按照入院顺序随机平分为观察组（42例）和对照组（42例）。观察组患者采用经皮穿刺椎体成形术（PVP）治疗,对照组采用经皮球囊椎体后凸成形术（PKP）。评估两组患者治疗后的预后效果。结果两组组内术前、术后视觉模拟量表（VAS）评分（观察组8.23分±0.65分vs 2.45分±0.34分,对照组8.21分±0.57分vs 2.42分±0.41分）差异均有统计学意义（t=51.06、53.44,P=0.00、0.00〈0.05）。两组间术前、术后VAS评分差异无统计学意义（P〉0.05）。两组患者的骨折复位总满意度（观察组92.86%,对照组95.24%）及骨水泥注入量相比,差异无统计学意义（P〉0.05）。观察组手术时间短于对照组,住院费用少于对照组,差异有统计学意义（P〈0.05）。结论 PVP用于治疗骨质疏松性椎体骨折不愈合临床效果显著,骨折复位良好,相较PKP更节约手术时间及住院费用。
Objective To explore the clinical application effect of percutaneous puncture vertebral plasty（PVP） in the treatment of osteoporotic vertebral fracture nonunion. Methods From May 2012 to May 2015, a total of 84 patients with osteoporotic vertebral fracture nonunion were enrolled, which included 45 males and 39 females, aged 61-79 years old with mean age of66.43 years old. All of them were randomly divided into observation group（n = 42） and control group（n = 42） at admission. The observation group was treated by PVP and control group by percutaneous kyphoplasty（PKP）, and the prognosis of 2 groups after treatment were evaluated. Results The differences in visual analogue scale（VAS） scores was statistically significant before and after treatment within 2 groups（8.23 ± 0.65 vs 2.45 ± 0.34 for observation group, 8.21 ± 0.57 vs 2.42 ± 0.41 for control group;t = 51.06, 53.44; P = 0.00, 0.00 〈0.05）. The difference in VAS scores was no statistically significant before and after treatment between 2 groups. No significant difference was observed in overall fracture satisfaction（92.86 % for observation group and95.24 % for control group） and the amount of bone cement injection（P〉0.05）. The operation time of observation group was shorter than that of control group, and hospital costs less than control group, the differences were statistically significant（P〈0.05）.Conclusion It is demonstrated that in the treatment of osteoporotic fracture nonunion, the clinical effect of PVP is remarkable with good fracture reduction, which is more economic than PKP in operation time and hospitalization costs.
出处
《生物医学工程与临床》
CAS
2016年第4期391-394,共4页
Biomedical Engineering and Clinical Medicine
